Stocks and Investing Stocks and Investing
Thu, March 2, 2023
Wed, March 1, 2023

Serge Belanger Reiterated (ARQT) at Strong Buy and Held Target at $46 on, Mar 1st, 2023


Published on 2024-10-28 02:02:34 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $46 on, Mar 1st, 2023.

Serge, nor any peers, have made any analyst calls on ARQT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources